Expression of a neuropilin-like protein, DCBLD2, is reduced in human calcific aortic valve disease (CAVD). DCBLD2-deficient mice develop bicuspid aortic valve (BAV) and CAVD, which is more severe in BAV mice compared with tricuspid littermates. In vivo and in vitro studies link this observation to up-regulated bone morphogenic protein (BMP)2 expression in the presence of DCBLD2 down-regulation, and enhanced BMP2 signaling in BAV, indicating that a combination of genetics and BAV promotes aortic valve calcification and stenosis. This pathway may be a therapeutic target to prevent CAVD progression in BAV.
Keywords: BAV, bicuspid aortic valve; BMP, bone morphogenic protein; CAVD, calcific aortic valve disease; DCBLD2, discoidin, CUB and LCCL domain containing 2; EC, endothelial cell; RT-PCR, reverse-transcription polymerase chain reaction; SMAD, homolog of Caenorhabditis elegans Sma and the Drosophila mad, mothers against decapentaplegic; TAV, tricuspid aortic valve; VIC, valvular interstitial cell; WT, wild type; aortic stenosis; aortic valve; bicuspid aortic valve; calcification; mouse models; pVIC, porcine valvular interstitial cell; siRNA, small interfering RNA.